Impax Asset Management Group PLC Neurocrine Biosciences Inc Transaction History

Impax Asset Management Group PLC

$15.6 Billion
Q2 2025

A detailed history of Impax Asset Management Group PLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Impax Asset Management Group PLC holds 115,000 shares of NBIX stock, worth $16.4 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

115,000

Previous 100,000 15.0%

Holding current value

$16.4 Million

Previous $11.1 Million 30.69%

% of portfolio

0.09%

Previous 0.07%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$87.54 - $128.18 $1.31 Million - $1.92 Million	15,000 Added 15.0%	115,000 $14.5 Million
Q1 2025 Apr 29, 2025	SELL	$107.22 - $153.29 $17.3 Million - $24.8 Million	-161,599 Reduced 61.77%	100,000 $11.1 Million
Q4 2024 Feb 04, 2025	BUY	$111.62 - $139.44 $19.7 Million - $24.6 Million	176,599 Added 207.76%	261,599 $35.7 Million
Q3 2024 Oct 30, 2024	BUY	$114.58 - $153.15 $4.01 Million - $5.36 Million	35,000 Added 70.0%	85,000 $9.79 Million
Q2 2024 Nov 08, 2024	SELL	$130.86 - $143.19 $4.58 Million - $5.01 Million	-35,000 Reduced 41.18%	50,000 $6.88 Million
Q1 2024 Apr 30, 2024	SELL	$130.4 - $143.74 $7.82 Million - $8.62 Million	-60,000 Reduced 54.55%	50,000 $6.9 Million
Q4 2023 Jan 26, 2024	SELL	$106.07 - $132.76 $2.65 Million - $3.32 Million	-25,000 Reduced 18.52%	110,000 $14.5 Million
Q3 2023 Nov 07, 2023	SELL	$94.02 - $117.1 $6.11 Million - $7.61 Million	-65,000 Reduced 32.5%	135,000 $15.2 Million
Q1 2023 May 10, 2023	BUY	$94.11 - $123.02 $2.35 Million - $3.08 Million	25,000 Added 14.29%	200,000 $20.2 Million
Q4 2022 Feb 09, 2023	BUY	$106.72 - $127.06 $2.67 Million - $3.18 Million	25,000 Added 16.67%	175,000 $20.9 Million
Q3 2022 Nov 08, 2022	BUY	$92.03 - $107.81 $13.8 Million - $16.2 Million	150,000 New	150,000 $15.9 Million
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $6.38 Million - $9.78 Million	-75,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$75.11 - $113.76 $5.63 Million - $8.53 Million	75,000 New	75,000 $6.49 Million
Q4 2019 Feb 13, 2020	SELL	$86.8 - $118.57 $1.91 Million - $2.61 Million	-22,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $1.84 Million - $2.23 Million	22,000 New	22,000 $1.98 Million

Others Institutions Holding NBIX

# of Institutions

663

Shares Held

102M

Call Options Held

290K

Put Options Held

214K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.6B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Impax Asset Management Group PLC with notifications on news.

Account

Impax Asset Management Group PLC Neurocrine Biosciences Inc Transaction History